摘要
本论文以黄渤海交界处长岛海域的紫蛇尾作为实验材料,按照国标法测定了紫蛇尾主要营养成分,采用正交实验法优化了紫蛇尾皂苷的提取工艺,并对紫蛇尾皂苷理化性质进行了测定,研究了紫蛇尾皂苷的提取、分离纯化,以及紫蛇尾皂苷的部分生物活性,包括:抗氧化活性,抑菌活性以及抗肿瘤活性,为紫蛇尾资源的开发利用提供必要的理论依据。
通过对采自长岛海域的紫蛇尾(整体)的营养成分(水分、灰分、蛋白质、总糖、粗脂肪、脂肪酸、氨基酸、无机元素)分析,结果显示紫蛇尾水分含量4.09%,灰分含量25.71%,蛋白质含量18.27%,总糖含量3.53%,粗脂肪含量1.74%。紫蛇尾营养元素丰富,其中Ca含量最高,其次是Mg、Fe。脂肪酸中不饱和脂肪酸占72.61%,尤其是富含人体必需的多不饱和脂肪酸EPA和α亚麻酸,并且必需氨基酸指数(EAAI)为25.90。可以预见,紫蛇尾具有广阔的潜在利用价值,可进一步考虑开发成海洋功能食品或新型动物性饲料。
采用L9(34)正交实验法,以皂苷产率为指标,研究提取温度、提取时间、料液比、提取次数4个因素对提取工艺的影响。以正交实验的实验结果为条件建立多元线性模型,所得到的统计参数分别为R = 0.914,F = 10.585,并用所建立的线性模型预测两个实验条件下的结果,结果可信,说明紫蛇尾皂苷的产率和提取工艺相关因素有显著的相关关系。
采用传统的溶剂浸提法得到紫蛇尾皂苷粗品,测定紫蛇尾皂苷的常规理化性质,包括:颜色反应、熔点、溶血指数、紫外特征吸收光谱和红外光谱。依次用水、20%乙醇,40%乙醇、60%乙醇、80%乙醇经过大孔树脂AB-8除去多糖和无机盐,收集40%乙醇洗脱部分,反复经过硅胶柱层析、Sephadex LH-20凝胶柱层析和反向硅胶柱层析分离纯化样品。
采用微弱发光仪测定紫尾皂苷的抗氧化活性,结果表明,在一定浓度范围内,紫蛇尾皂苷抗氧化能力随着浓度增大呈蛇线性增强,紫蛇尾皂苷抑制过氧化氢的能力最强,抑制超氧阴离子的能力次之,抑制羟基的能力最弱。紫蛇尾皂苷具有显著的抗氧化活性,可以考虑将紫蛇尾皂苷开发成为新型的抗氧化药剂。
采用滤纸片法测定紫蛇尾皂苷的抑菌能力,采用改进的琼脂稀释法测定紫蛇尾皂苷的最低抑菌浓度,结果表明粗皂苷经过大孔树脂AB-8富集40%乙醇洗脱部位抑菌活性比粗皂苷显著增强。经过初步硅胶柱层析后,氯仿部分抑菌活性最强,其次是氯仿:甲醇:水= 9:1:0.1部分和氯仿:甲醇:水= 8:2:0.2部分。大肠杆菌、枯草杆菌的最低抑菌浓度(MIC)是0.0443 mg/mL,是粗皂苷经大孔树脂40%乙醇洗脱部分。金黄色葡萄球菌、产气杆菌、变形杆菌、青霉、毛霉、黄曲霉、啤酒酵母的最低抑菌浓度MIC值是0.0148 mg/mL,是氯仿条带1部分。各部分对面包酵母均无抑制作用。
采用SRB法测定紫蛇尾粗皂苷对人肺癌NCI-H460细胞和肝癌HepG2细胞的抑制能力,结果表明,给药剂1000mg/L时,抑制率分别达到38.03%和34.57%,但是给药剂量较低时抑制率下降幅度明显,没有显著的抑制效果。
In this paper, Ophiopholis mirabilis from the Changdao Archipelago was used as the experimental material. The major nutritional components of Ophiopholis mirabilis was determined.The extraction process of ophiurasaponin was optimized by the orthogonal experiment. The physical and chemical properties of ophiurasaponin were determined. We aiso studied on the extraction, purification and part of the biological activity of ophiurasaponin,including antioxidant activity, antimicrobial activity and antitumor activity.These studies provided the necessary theoretical basis for the development and utilization of Ophiopholis mirabilis.
We determined the major nutritional components of Ophiopholis mirabilis(overall), including moisture, ash, protein, total sugar,rude fat, fatty acids, amino acids and inorganic elements. The concentration of moisture, ash, protein, total sugar and rude fat were 4.09%, 25.71%, 18.27%, 3.53% and 1.74%, respectively. The concentration of Ca, Mg, Fe were high among the inorganic elements. Unsaturated fatty acids was accounted for 72.61% of total fatty acids.There were especially rich in essential polyunsaturated fatty acids,such as EPA andαlinolenic acid.And the essential amino acid index (EAAI) was 25.90. Ophiopholis mirabilis had broad potential value,and it can be further considered the development of new functional food or animal feed.
Orthogonal experiment has been used to investigate the extraction process of ophiurasaponin. The extraction temperature, extraction time, ratio of the material to water and times of extraction were selected as variable parameters. Their different effects on the yield of ophiurasaponin that extracted from Ophiopholis mirabilis were studied by the L9(34)experimental design method. In addition, a multiple linear regression(MLR) model, in which the yield of ophiurasaponin was as the dependent and the experiment conditions of the orthogonal experiment was as the independent, was firstly constructed to predict the yield of ophiurasaponin of two experiment conditions in the orthogonal experiment. The statistic parameters were R = 0.914, F = 10.585. And the MLR model was used to predict yields of ophiurasaponin of two experiments. The predicted results were in good agreement with the experimental values, indicating that the model can be used to predict the yield of ophiurasaponin.
The crude ophiurasaponin was obtained by the traditional solvent extraction.We determined the physical and chemical properties of ophiurasaponin , including color reaction, melting point, hemolytic index, UV absorption spectra and infrared spectra.Polysaccharides and inorganic salts were removed through the AB-8 macroporous resin followed by water, 20% ethanol, 40% ethanol, 60% ethanol, 80% ethanol. Some 40% ethanol elution was through silica gel column chromatography, Sephadex LH-20 silica gel column chromatography, and reverse column chromatography.
Ultra-Weak Luminescence Analyzer was used to detect the antioxidant activity of ophiurasaponin.The results showed that the antioxidation capabilities increased linearly with the increasing of the concentration of ophiurasaponin in a certain range. The result showed that ophiurasaponin from ophiopholis mirabilis had strongest inhibition to hydroxyl, weakest to hydroxyl radicals, and mediate to superoxide. Ophiurasaponin from ophiopholis mirabilis had significant antioxidant activity, it may be considered to develop into a new type of antioxidant agents.
Using circular filter paper method , the antibacterial activity of ophiurasaponin was detected. The minimum inhibitory concentration (MIC) of ophiurasaponin was determined by modified agar dilution method. The results showed that the antibacterial activity of 40% ethanol elution was enhanced than the crude ophiurasaponin. After the initial silica gel column chromatography, the part of the chloroform had the strongest antibacterial activity, followed by the part of chloroform: methanol: water = 9:1:0.1 and chloroform: methanol: water = 8:2:0.2 . The MIC of Escherichia coli and Bacillus subtilis was 0.0443mg/mL,and it was the 40% ethanol elution through macroporous resin.The MIC of Staphylococcus aureus, Aerobacter aerogenes, Proteus, Penicillium, Mucor, Aspergillus, Saccharomyces cerevisiae was 0.0148mg/mL,and it was the first strip of chloroform. It had no inhibitory effect on Saccharomyces cerevisiae Hansen.
Cytotoxic effect of human liver cancer cell NCI-H460 and human lung cancer cell HepG2 were assayed using SRB method in vitro.The results showed that the inhibition rates were 38.03% and 34.57% when the drug reached 1000mg/L.The inhibition rate decreased rapidly when the adminitration was low.In short, Ophiurasaponin had no significant inhibition of tumor cells.
引文
[1]林文翰.我国海洋生物的药学研究思考[J].中国天然药物,2006,4(1):10-14.
[2]易杨华,李玲,汤海峰.海洋药物研究进展[J].上海医药,2003,24(2):75-77.
[3]翁心华.抗微生物治疗研究进展[J].国外医学(微生物学分册),2001,24(4):1.
[4]许实波.海洋生物制药[M].北京:化学工业出版社,2002.18.
[5]焦炳华.海洋生命活性物质和海洋药物的研究与开发[J].第二军医大学学报,2006,27:5-7.
[6]吴梧桐,王友同,吴文俊.海洋活性物质研究若干进展[J].药物生物技术,2007,7(3),179-183.
[7]郭跃伟.欧洲海洋药物的研究现状及对我国海洋药物研究的启示[J],中国新药杂志,2001,2:28-30.
[8]刘晶晶,陈全震,曾江宁.海洋微生物活性物质的研究进展[J].海洋科学研究,2007,25(1):55-65.
[9] Williams PG,Yoshida WY,Quon MK,et al. Ulongapeptin,a cytotoxic cyclic depsipeptide from a Palauan marine cyanobacterium Lyngbya sp.[J].J Nat Prod,2003,66(5) :651-654.
[10] Pan W,Liu X,Ge F,et a1.Perinerin,a novel antimicrobial peptide purified from the clamworm Perinereis aibuhitensis grube and its partial characterization[J].J Biochem (Tokyo), 2004,135 (3):297-301.
[11] Iijima R,Kisugi J,Yamazaki M.A novel antimicrobial peptide from the sea hare Dolabella auricularia[J].Dev Comp Immunol,2003,27(4):305-309.
[12] Torres YR,Berlinck RG,Nascimento GG,et a1.Antibacterial activity against resistant bacteria and cytotoxicity of four alkaloid toxins isolated from the marine sponge Arenosclera brasiliensis [J].Toxicon,2002,40(7):885-892.
[13] Satitpatipan V,Suwanborirux K.New nitrogenous Germacranes from a Thai marine sponge,Axinyssan sp.[J].J Nat Prod,2004,67(3):503-510.
[14] Manam RR,Teisan S white DJ,et a1.Lajollamycin,a nitro-tetraene spiro-beta-lactone–gamma -lactam antibiotic from the marine actinornycete Streptomyces nodosus.[J].J Nat Prod, 2005,68 (2):240-251.
[15] Y. Murata,N. U. Sata.Isolation and Structure of Pulcherrimine, a Novel Bitter-Tasting Amino Acid, from the Sea Urchin (Hemicentrotus pulcherrimus) Ovaries[J].J. Agric. Food Chem. 2000, 48,:5557-5560.
[16] Fukunaga, Kenji,Hossain, ,et al.Marine phosphatidylcholine suppresses 1,2-dimethydrazine - induced colon carcinogenesis in rats by inducing apoptosis[J]. Nutrition research, 2008,28(9) :635-640.
[17]牛宗亮,王荣镇,董新伟,等.马粪海胆生殖腺营养成分的含量测定[J].中国海洋药物,2009,28(6) : 26-30.
[18] Beress A,Wassermann O,Tahhan S,et al.A new procedure for the isolation of anti-HIV compounds (polysaccharides and polyphenols) from the marine alga Fucus vesiculosus.[J].J Nat Prod,1993,56:478-488.
[19] Beutler.J.A,Mckee T C,Fuller R W,et al.Frequent occurrence of HIV-inhibitory sulfated polysaccharides inmarine invertebrates[J].Antiviral Chem.&Chemother,1993,4(3):167-172.
[20] Neushut,M.Antiviral carhohydrate from marine red algae bioactive-compounds from marine organisms with empilasis on the Indian ocean an indo chited states symposium[J]. Journal of Experimental Marine Biology andEcology ,1991:275-281.
[21] Labrecque DR,Pesch LA.Preparation and partial characterization of Hepatic regenerative stimulatory substance from rat liver[J].J Physiol,1975:248-273.
[22]关美君,林文翰,丁源.海洋药物-二十一世纪中国药学研究的新热点[J].中国海洋药物, 2001,1:1-5.
[23]易杨华,李玲.海洋药物研究展望与对策[J].第二军医大学学报,2001,22(9):801-802.
[24]管华诗.我国海洋创新药物的研究和开发[J].中国天然药物,2006,4(1):1.
[25]姜云垒,冯江.动物学[M].北京:高等教育出版社,2006.178-186.
[26] David L.Pawsonn,Doris J,et al.A taxonomic guide to the Echinodermata of the south Atlantic Bight,USA:1 Sea cucumbers (Echinodermata:holothuroidea) [J]. Zootaxa, 2010, 2449:1-48.
[27] Zhang W,Guo YW,Gu Y.Secondary metabolites from the South China Sea invertebrates: chemistry and biological activity[J].Curr Med Chem. 2006,13(17):2041-2090.
[28]李海芳,陈瑶,杨梦照,等.棘皮动物天然产物的研究进展[J].中国海洋药物,2008, 27(4):52-59.
[29]攀廷俊,杜玉堂,丛日山,等.棘皮动物再生研究进展[J].中国海洋大学学报,2007,37(4):563-568.
[30]宋志东,李培玉,张利民,等.棘皮动物补体系统的研究进展[J].水产科技情报,2007,34(2):62-65.
[31]孟繁伊,麦康森,马洪明,等.棘皮动物免疫学研究进展[J].生物化学与生物物理进展,2009,36(7):803-809.
[32]张峰.棘皮动物体内防御机制的研究进展[J].大连水产学院学报,2005,20(4):340-344.
[33] Jean Mamelona,Emilien Pelletier.Producing High Antioxidant Activity Extracts from Echinoderm by Products by using Pressured Liquid Extraction[J],Biotechnology,2010,9(4):523-528.
[34] Jean Mamelona,Richard Saint-Louis,Emilien Pelletier.Nutritional composition and antioxidant properties of protein hydrolysates prepared from echinoderm byproducts[J]. International Journal of Food Science &Technology, 2010,45(1):147-154.
[35] Geoffroy Coteur, Michel Warnau, Michel Jangoux.Reactive oxygen species (ROS) production by amoebocytes of Asterias rubens (Echinodermata) [J]. Fish & Shellfish Immunology , 2002, 12(3): 187-200.
[36] Osama Y. Althunibat, Ridzwan Bin Hashim, Muhammad Taher,et al.In Vitro Antioxidant and Antiproliferative Activities of Three Malaysian Sea Cucumber Species[J]. European Journal of Scientific Research, 2009, 37 (3):376-387.
[37] L.S.Dolmatova,M.G.Eliseikina,V.V.Romashina.Antioxidant Enzymatic Activity of Coelomocytes of the Far East Sea Cucumber Eupentacta fraudatrix[J]. Journal of Evolutionary Biochemistry and Physiology , 2004, 40 (2),126-135.
[38]廖玉麟.中国动物志.棘皮动物门[M].北京:科学出版社,1997.
[39]刘伟,廖玉麟,李新正.中国海砂海星科(棘皮动物门,海星纲)种类记述[J].动物分类学报,2008,32(1):234-240.
[40]攀廷俊,杜玉堂,丛日山,等.罗氏海盘车腕再生过程的组织学研究[J].中国海洋大学学报:自然科学版,2005,35(4):559~563.
[41] Piscopo S,De Stefano R,Thorndyke M C,et a1.Alteration and recovery of appetitive behaviour following nerve section in the starfish Asterins rubens [J].Behav Brain Res, 2005,164 (1):36-41.
[42]张立新,范晓,石建功,等.海燕(Asterina pectinifera)化学成分研究[J].中国海洋药物,2004,1:6-10.
[43] Roccatagfiata A J,Maier M S,seldes A M.Starfish saponins, part 2.Steroidal oligoglycosides from the starfish Cosmasterias lurida[J].J Nat Prod,1994,57:747-754.
[44] Iorizzi M,Bifulco G,de Riceardis F,et al.Starfish saponins,Part 53. A reinvestigation of the polar steroids from the starfish Oreaster reticulatus:isolation of sixteen steroidal oligoglycosides and six polyhydroxysteroids[J].J Nat Prod,1995,58:10-26.
[45]王伟红.赤海星中生物活性化学成分的研究[D].沈阳药科大学,2003.
[46]王兵,郑意端.海星总皂苷年抗肿瘤作用的实验研究[J].中草药,2001,32(3):244-245.
[47]潘广昌,郭承华,刘传琳,等.砂海星营养成分的含量测定[J].中国海洋药物,2006,25(6):46-48.
[48]张立新,范晓,韩丽君.罗氏海盘车(Asterias rollestoni)中几种化合物的提取分离和结构鉴定[J].天然产物研究与开发,2005,17(1):35-37.
[49]李厚金,李淑青,王丰,等.长棘海星的体内脂肪酸成分及其生物学意义分析[J].中山大学学报(自然科学版),2009,48(5):55-60.
[50] Leonard LA,Strandberg JD,Winkelstein JA.Complement-like activity in the sea star,Asterias forbesi[J].Dev Comp Immunol,1990,14(1):19-30.
[51] Cancre I,Wormhoudt AV,Gal Y.Heparin-binding molecules with activity in regenerating- tissue of starfish Asterias rubens[J].Comparative Biochemistry and Physiology,1999,123(3),:285-292.
[52] Palagiano E,Marino SD,Minale LR,et al.Ptilomycalin A,Crambescidin 800 and Related New Highly Cytotoxic Guanidine Alkaloids from the Starfishes Fromia monilis and Celerina heffetnani [J]. Tetrahedrom, 1995, 51: 12293-12300.
[53]李军,蒋碧蓉,吴红梅,等.海星多糖的提取分离与抗氧化活性研究[J].广东化工,2010,37(2):188-193.
[54] L.Stabili,M.Lassagues,M.Pastore.Preliminary Study on the Antibacterial Capabilities of Eggs of Paracentrotus lividus (Echinodermata: Echinoidea) [J]. Journal of invertebrate pathology, 1996,67:180-182.
[55]国家中医药管理局.中华本草(第9卷)[M].上海:上海科学技术出版社,1999,9:250-252.
[56]牛宗亮,王荣镇,董新伟,等.马粪海胆生殖腺营养成分的含量测定[J].中国海洋药物,2009,6:26-30.
[57]张忠玲,朱波,张翠,等.海胆肠多糖致Bel7402人肝癌细胞凋亡的扫描电镜观察[J].电子显微学报,2003,22(6):467-467.
[58]阎红.白棘三列海胆的化学成分及药理活性研究[D].吉林农业大学,2008.
[59]许伟定,何平,王丽梅,等.光棘球海胆性腺氨基酸组成的研究[J].大连水产学院学报,2009,24(6):583-586.
[60] Murata Y., Sata N. U.. Determination of a novel bitter amino acid,pulcherrimine, in the gonad of the green seaurchinHemicentrotus pulcherrimus[J]. Fisheries Science, 2001, 67,:341-345.
[61] Murata Y., Sata N. U..Isolation and Structure of Pulcherrimine, a Novel Bitter-Tasting Amino Acid, from the Sea Urchin (Hemicentrotus pulcherrimus) Ovaries[J].J. Agric. Food Chem. 2000, 48:5557-5560.
[62] Meizman MS,Mastroianni A,Strauss JF.Fatty acid composition of unfertilized and fertilized eggs of the sea urchin,Arbacis punctulata [J]. Lipids,1978,13(11):823-824.
[63]高翼,奚涛,刘纯慧,等.海胆壳蛋白的分离纯化及抗肿瘤活性[J].中国天然药物,2006,4(6):464-467.
[64] Kariya Y,Watanabe S.0chiai Y.etal.Glyeosaminoglycan from the body wall of the scucumber Stichopus japanifus[J].Comp Biochem Physiol(B),1990,96(2):387-392.
[65]孙玲,徐迎,许华临.朝参酸性粘多糖对细胞免疫的增强作用[J].生物化学与生物物理进展,1991,18(5):394-399.
[66]马天舒,葛迎春.海参活性物质的药理研究进展[J].特产研究,2003,1:57-61.
[67] Jeremian Villasin,Christopherm Pomory. Antibacterial activity of extracts from the body wall of Parastichopus parvimensis (Echinodermata: Holothuroidea)[J]. Fish & Shellfish Immunology ,2000, 10,:465–467.
[68]樊绘曾,陈菊娣,吕堵宏,等.玉足海参酸性多糖的研究[J].药学学报,1983,18(3):203‐205.
[69]王璐.刺参多糖对荷瘤小鼠抗肿瘤及免疫调节功能的研究[D].大连:辽宁师范大学,2005.
[70]吴萍茹,方金瑞,黄维真,等.二色桌片参的化学成分研究Ⅱ.二色桌片参多糖‐l‐?一种新的岩藻聚糖[J].中国海洋药物,2000,74:4‐7.?
[71] Maier M S,Roccatagliata AJ,KurissA,et a1.Two new cytotoxic and virucidal tfisulfated triterpene glycosides from the Antaretie sea cucumber Staurocucumis liouvillei[J].J Nat Prod, 2001,64:732-736.
[72]王增蕾.仿刺参和一种肉芝软珊瑚化学成分及生物活性研究[D].第二军医大学,2009.
[73] Rodriguez E,Gonzalwz M,Caride B,et al.Nutritional value of Holothuria forskali protein and effects on serum lipid profile in rats[J].J Physicl Biochem,2000,3,56(1)?:39-43.
[74]高森.三种海参降血脂及作用机制的比较研究[D].中国海洋大学,2008
[75]赵芹.海参胶原蛋白多肽抗氧化活性的研究[D].中国海洋大学,2008
[76] V.Sadie mills,Timothy Ohara,Amphilepis neozelandica sp.nov.,the first record of the Amphilepididae in New Zealand waters (Echinodermata: Ophiuroidea) [J].Zootaxa, 2010, 2514:47-54.
[77] Sabine stohr,Melih ertan,Cinar,et al.Brittle stars(Echinodermata:Ophiuroidea) from the southern coast of Turkey (eastern Mediterranean):new records and revision of Amphiodia obtecta Mortensen, 1940[J].Zootaxa, 2010,2483:45-57.
[78] Masanori Okanishi,Toshihiko Fujita.A New Species of Asteroschema (Echinodermata: Ophiuroidea :Asteroschematidae) from Southwestern Japan[J].Species diversity, 2009, 14 (2):61-68.
[79] Milena Benavides-serrato,Timothyd.Ohara.A new species in the Ophiocoma erinaceus complex from the South-west PacificOcean (Echinodermata: Ophiuroidea: Ophiocomidae) [J].Memoirs of Museum Victoria ,2008,65 :51-56.
[80] Andersson L, Bohlin L, Iorizzi M,et al. Biological activity of saponins and saponin-like compounds from starfish and brittle-stars[J].Toxicon,1989,27(2):179-188.
[81] M.Valeria D’Auria, Luigi Gomez Paloma. Luigi MinaW,et al.Isolation, Structure Characterization and Conformational Analysis of a Unique 4a,Sa-Epoxysteroid Sulphate from the Okinawan Ophiuroid Ophiomasfix annulosa[J]. Tehakedron Letters, 1992,33 (32),:4641-4644.
[82] V. V. Sova,é. V. Levina, P. V. Andriyashchenko, et al.Effect of polyhydroxysteroids from starfish and brittle stars on the activity ofβ-1,3-glucanases[J]. Chemistry of natural compounds,1994,30(5):599-602.
[83] Aminin DL, Agafonova IG, Fedorov SN. Biological activity of disulfated polyhydroxysteroids from the Pacific brittle star Ophiopholis aculeate[J]. Comparative Biochemistry and Physiology Part C: Comparative Pharmacology and Toxicology, 1995, 112(2):201-204.
[84] Mansour Maged P,Holdsworth Daniel G,Forbes Susan E,et al.High contents of 24:6(n-3) and 20:1(n-13) fatty acids in the brittle star Amphiura elandiformis from Tasmanian coastal sediments[J]. Biochemical systematics and ecology,2005,33:659-674.
[85]廖玉麟.中国动物志,无脊椎动物,第四十卷,棘皮动物门,蛇尾纲[M].北京:科学出版社,2004:240-242.
[86]徐勤增,李瑞香,王宗灵,等.南黄海夏季大型底栖动物分布现状[J].海洋科学进展,2009,27(3):393-399.
[87] S.K.Donovan,D.N.Lewis,P.Crabb,et al.A field guide to the Silurian Echinodermata of the British Isles:Part 2-Crinoidea,minor groups and discussion[J].Proceedings of the Yorkshire geological society,2008,57(1):29-60
[88] Michel Roux,Nadia Ameziane,Marceleaume. The genus Teliocrinus (Crinoidea, Echinodermata): a key taxon among pentacrinid stalked crinoids[J]. Zoological Journal of the Linnean Society, 2009, 155:22–39.
[89] Chang K-H., Chen C-P,Chen, J-C. Reproductive biology of the crinoid Comanthus parvicirrus and Comatella maculata(Echinodermata: Crinoidea)[J]. Bull. Inst. zool. Acad.Sin, 1990,29:165-172.
[90] Hisanori Kohtsuka, Hiroaki Nakano.Development and growth of the feather star Decametra tigrina(Crinoidea), with emphasis on the morphological differences between adults and juveniles [J]. Mar Bio Ass, 2005,85:1503-1510.
[91] Mariusa A,Salamon,Przemyslaw.Cyrtocrinids (Echinodewmata : Crinoidea ) from upper jurassic stramberk-type limestones in southern poland [J].Palaeontology,2010,53(4):869-885.
[92] Masami Obuchi,Ichizo Kogo,Yoshihisa Fujita.A new brooding feather star of the genus Dorometra (Echinodermata:Crinoidea:Comatulida:Antedonidae) from the Ryukyu Island, southwestern Japan[J]. Zootaxa 2008:61–68.
[93] Kathy A,hollis,William I.ausich.Ontogeny and life-history strategy of Barycrinus (Crinoidea, Mississippian) [J]. Lethaia,2009,42(2):138-145.
[94]汤海峰,易杨华,张淑瑜,等.海星皂苷的研究进展[J].中国海洋药物,2004,23(6):48-57.
[95]邹峥嵘,易杨华,张淑瑜,等.海星皂苷的研究进展[J].中国海洋药物,2004,1:46-53.
[96]张豁中.棘皮动物中皂甙的分布及其分离提取[J].海洋药物,1983,2:109-117.
[97]郭承华,贺凤丽,李长华.罗氏海盘车海星皂甙的提取分离及其分析鉴定[J].烟台大学报(自然科学与工程版),1995,4:13-17.
[98]郝林芳,李八方.多棘海盘车皂甙的初步研究[J].海洋水产研究,1998,19(2):81-87.
[99]郭承华,张恒云,刘丽娟.海燕组织中海星皂甙的分布及溶血指数的测定[J].中国海洋药物,2000,3:12-14.
[100]郭承华,贺凤丽,李长华.罗氏海盘车海星皂贰的提取分离[J].烟台大学报(自然科学与工程版),1995,4:13-17.
[101]郭承华,曹建国,宁黔冀.罗氏海盘车、海燕、金氏真蛇尾皂甙的制备及性质鉴定比较[J].中国海洋药物,2000,4:28-30.
[102]潘敏翔,吴久鸿,易杨华,等.疣海星的皂苷类成分研究[J].全国海洋生物技术与海洋药物学术会议论文集,2006:173-176.
[103]袁文鹏,丛日山,杨秀霞,等.水溶性海参皂苷的分离纯化及其抗真菌活性研究[J].山东大学学报(理学版),2007,42(5):69-78.
[104]樊廷俊,张铮,袁文鹏,等.水溶性海星皂苷的分离纯化及其抗真菌活性研究[J].山东大学学报(理学版),2008,43(9):1-5.
[105]汪茂田,谢培山,王忠东,等.天然有机化合物提取分离与结构鉴定[M].北京:化学工业出版社,2004,8:31-35.
[106]文震,党志,宗敏华,等.超临界CO2萃取海星皂甙[J].精细化工,2006,23(7):657-660.
[107]韩艳玲,周月,李敏晶.用复合酶法提取海燕中总皂苷的工艺研究[J].大连水产学院学报,2009,24:206-208.
[108]黎海彬,王邕,李俊芳,等.微波辅助提取技术在天然产物提取中的应用[J].现代食品科技,2005,21(3):148-150.
[109]李敏晶,韩艳玲,周月,等.正交设计优化海燕总皂苷的微波提取工艺[J].广东化工,2010,37(7):19-23.?
[110]汪茂田,谢培山,王忠东,等.天然有机化合物提取分离与结构鉴定[M].北京:化学工业出版社,2004,8:31-35.
[111]史作清,何炳林.大孔树脂孔结构的表征[J].离子交换与吸附,1991,7(1):50-55.
[112]李善吉,伍胜君.大孔树脂的应用研究概况[J].广东轻工职业技术学院学报,2005,4(2):11-13.
[113]李琛.大孔树脂在中药成份分离中的应用进展[J].湖北中医杂志,2007,29(10):64-65.
[114]白夺龙,杨开华.大孔吸附树脂分离纯化技术及应用[J].海峡药学,2007,19(9):96-99.
[115] Lih-Geeng Chen;Ching-Chiung Wang.Preparative separation of oligostilbenes from Vitis thunbergii var.taiwaniana by centrifugal partition chromatography followed by Sephadex LH-20 column chromatography[J]. 2009,66(1) :65-70.
[116]张慧丽,孙印石,郑毅男.葡聚糖凝胶LH-20柱层析法分离人参皂苷Re的研究[J].吉林农业大学学报,2005, 27(3) :293-295.
[117]章育中,郭希圣.薄层层析法和薄层扫描法[M].北京:中国医药科技出版社,1990.
[118]于世林.高效液相色谱法及应用[M].北京:化学工业出版社,2001.
[119] Levina EV ,Andriyashchenko PV ,Kalinovsky AI , et al . Steroid compounds from the starfish Lysastrosoma anthosticta collected in the Sea of Japan[J]. Russian Chemical Bulletin , International Edition ,2002 ,51 (3) :535-539.
[120] Levina EV ,Kalinovskii AI ,STonik VA , et al.Steroidal polyols from Far-Eastern starfishes Henricia sanguinolenta and H. leviuscula [J]. Russian Chemical Bulletin , International Edition ,2003 ,52 (7) :1623-1628.
[121]潘敏翔,吴久鸿,易杨华,等.疣海星中一个新的多羟基甾醇皂苷[J].中国天然药物,2006,4(5):344-346.
[122]巫军,易杨华,吴厚铭,等.黑乳海参中两个新的四环三萜化合物[J].中国天然药物,2005,3(5):276-279.
[123]闫冰,李玲,易杨华,等.糙海参中三萜皂苷活性成分的研究[J].第二军医大学学报,2005,26(6):626-630.
[124]喇明平,易杨华,李玲,等.叶瓜参中的三个海参皂苷[J].中国天然药物,2008,6(4):254-258.
[125]王晓华,李玲,易杨华,等.花刺参中两个新的三萜皂苷[J].中国天然药物,2006,4(3):176-180.
[126] Gorshkov BA,Kapustina II,Kicha AA.Stimulatory effects of starfish sapogenins on molluscan heat[J].Comparative Biochemistry and Physiology,1998,120:235-239.
[127]汤海峰,易杨华,张淑瑜,等.海星皂苷的研究进展[J].中国海洋药物杂志, 2004, 23 (12) :48-57.
[128] De Marino S,Iorozzi M,Zollo F,et al.Isolation,structure elucidation,and biological activity of the steroid oligoglycosides and polyhydroxysteroids from the Antarctic starfish Acodontaster conspicuous[J].J Nat Prod,1997,60(10) :959-966.
[129]樊廷俊,袁文鹏,丛日山,等.仿刺参水溶性海参皂苷的分离纯化及其抑瘤活性研究[J].药学学报,2009,44(1):25-31.
[130]邹峥嵘,易杨华,姚新生等.二色桌片参皂苷intercedenside A的抗真菌和抗肿瘤活性[ J ].中国药理学通报,2005,6:761-762.
[131]巫军,易杨华,吴厚铭,等.黑乳海参皂苷nobiliside A的体外抗真菌及抗肿瘤活性[J].中国药理学通报,2007,23(1):139-140.
[132]韩华,易杨华,喇明平,等.糙海参皂苷Scabraside A、B的抗真菌和抗肿瘤活性[J].中国药理学通报,2008,24(8):111-1112.
[133]程光,张赟,章翔,等.面包海星皂苷-1对恶性胶质瘤细胞系U87MG增殖抑制的体外研究[J].脑与神经疾病杂志,2008,16(5):575-578.
[134] Roccatagliata AJ,Maier MS,SeldesAM,el al.Antivirial sulfated steroids from the ophiuroid Ophioplocus janarii[J].J Nat Prod,1996,59(9):887-889.
[135] Roccatagliata AJ,Maier MS,Seldes AM.New sulfated polyhydroxysteroids from the Antarctic ophiuruid Astrogoma agassizii[J].J Nat Prod,1998,61(3):370-375.
[136]潘广昌,郭承华,彭伟兵,等.砂海星(Luidia quinaria von Martens)皂苷的精制与细胞毒活性研究[J].中外健康文摘,2006,3(10):36-37.
[137]周鹏,顾谦群,王长云.海星皂昔及其活性成分研究概况[J].海洋科学,2000,24(2):35-37.
[138] lvanehina NV,Kicha AA,Kalinovsky AI,et al.Hemolytic polar steroidaI constituents of the starfish Asteropecten[J]. J Nat Prod,2000,63(8): 1178-1181.
[139]郭承华,张恒云,刘丽娟.海燕组织中海星皂甙的分布及溶血指数的测定[J].中国海洋药物,2000,3,12-14.
[140] Kicha A A,Ivanchina N V,Gorshkova I A,et a1.The distribution of free sterols, polyhydroxy- steroids and steroid glycosides in various body components of the starfish[J].Patiria (=Asterina) pectinifera.Comparative Biochemistry and Physiology,Part B.2001,28(1):43-52.
[141]文震,党志,宗敏华,等.不同方法制备的海星皂甙细胞毒性评价[J].海洋通报,2006,25(6):26-30.
[142] lvanchina N V,Kicha A A,Kalinovsky A I,et al.Hemolytic polar steroidal constituents of the starfish Aphelasterias japonica[J].J Nat Prod,2000,63(8):1178-1181.
[143] Choi DH,Shin S,Park IK.Characterization of anfimiembial agents extracted from Asterina pectinifera[J].Int J Antimicrob Agent,1999,11:65-68.
[144]刘文杰,周培根.多棘海盘车皂甙抗菌活性研究[J].天然产物研究与开发,2005,17(3):283-286.
[145]丛日山,袁文鹏,樊廷俊,等.仿刺参水溶性海参皂苷的分离制备及抗真菌活性的研究[J].中国海洋大学学报,2006,36(6):959-964.
[146]袁文鹏,丛日山,杨秀霞,等.水溶性海参皂苷的分离纯化及其抗真菌活性研究[J].山东大学学报(理学版),2007,42(5):69-78.
[147] Severine Van Dyck, Pascal Gerbaux,Patrick Flammang.Elucidation of molecular diversity and body distribution of saponins in the sea cucumber Holothuria forskali(Echinodermata) by mass spectrometry[J]. Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology,2009,152(2):124-134.
[148] Chenghua Guo,Xuexi Tang,Xinwei Dong,et al.Studies on the expectorant, antitussive and antiasthmatic properties of asterosaponin extracted from Luidia quinaria[J].African Journal of Biotechnology,2009,8 (23): 6694-6696.
[149]郭承华,董新伟,贺君,等.海燕皂苷的抗炎活性的初步研究[J].中国生化药物杂志,2010,31(4):259-260.
[150]周鹏,顾谦群,王长云.海星皂昔及其活性成分研究概况[J].海洋科学,2000,24(2):35-37.
[151] Kieha AA,Kalinovsky AI,Ivan ehina NV,et al.New semid ycosides from the deep-water starfish Mediaster murrayi[J].J Nat Prod ,1999,62:279-282. ?
[152] Ivanehina NV,Kieha AA,Kalinovsky AI,et al.New steroid glycosides from the starfish Asterias rathbuni[J].J Nat Prod,2001,64:945-947.
[153] Qi JH,Ojika M,Sal(agaII1i Y.Linckesides A and B,two neuritogenie steroid glycosides from the Okinawan starfish Linckia laevigata[J].Bioorg Med chem.,2002,10:1961-1966.
[154] Mats MN,Korkhov VV,Stepanov VR,et al.The contraceptive activity of triterpene glycosides-the total sum of holotoxins A1 and B1 and holothurin A in an experiment[J]. Farmakologiiai Toksikologiia,1990,53(2):45-47.
[155] Santhakumari G,Stephen J.Antimitotle effects of holothurin [J]. Cytologia, 1998, 53:163 -165.
[156]郝林华,李八方.多棘海盘车营养成分的研究[J].水产学报,1998,22(4):385-388.
[157]郭承华,程岩,刘雪梅,等.海燕生殖腺中几种营养成分含量的测定[J].海洋科学,2004,28(1):79-81.
[158]潘广昌,郭承华,刘传琳,等.砂海星营养成分的含量测定[J].中国海洋药物,2006,6(25):46-48.
[159] GB/T 5009.3-2003,食品中水分的测定[S].
[160] GB/T 5009.4-2003,食品中灰分的测定[S].
[161] GB/T 5009.5-2003,食品中蛋白质的测定[S].
[162] GB/T 5009.6-2003,食品中脂肪的测定[S].
[163]申瑞玲,董吉林,王章存.GC-MS对不同比例胡麻油和菜籽油混合油脂肪酸分析[J].粮食与油脂,2007, 12:43-45.
[164]乔英,丁艳霞,董学畅,等.原子吸收和原子荧光光谱法测定灵芝中的重金属含量[J].云南民族大学学报(自然科学版),2006,15(4):315-317.
[165]孙云,刘杰,刘佳佳,等.苯酚-硫酸法测定菊苣根中总糖的含量[J].中国民族民间医药,2008,4:12-13.
[166]贾桂兰,钟声,黄冬凌.用日立835-50型氨酸分析仪测定色氨酸方法的试验报告[J].氨基酸杂志,1988,(1):13-16.
[167] Sinclaie HM.The relative importance of essential fatty acids of the linoleiec and linolenic families:studies with an Eskimo diet[J].Prog Lipid Res,1981,20,:897- 899.
[168]陶国琴,李晨.α-亚麻酸的保健功效及应用[J].食品科学,2000,21(12):140-143.
[169]戴传超,袁生,刘吉华.DHA和EPA的生理功能及其应用[J].微生物学杂志,1998,18(4):48-50.
[170]胡立志.鱼油中含有的脂肪酸EPA和DHA[J].中国油脂,1993,18(6):59-63.
[171] GB2762–2005,食品中污染物限量[S].
[172]郭澄联,傅德贤,何慧,等.紫海胆生殖腺和棘壳中的金属元素[J].热带海洋,2000,19(2):82-85.
[173]牛宗亮,王荣镇.,董新伟,等.马粪海胆生殖腺营养成分的含量测定[J].中国海洋药物,2009,28(6):26-30.
[174] Henriette Selck,Maria E. Granberg,Valery E. Forbes- Impact of sediment organic matter quality on the fate and effects of fluoranthene in the infaunal brittle star Amphiura filiformis[J].Marine Environmental Research, 2005,59:19-45.
[175] Pellettpl,Yongvr. Nutritional evaluation of proteinfoods[ M] .Tokyo :The United National University,1980:26- 29.
[176]于辉,李华,刘为民,等.梁子湖三种鱼白鱼肉质分析[J].水生生物报,2005 ,29(5) :502- 506.
[177] Agostino Casapullo,Ester Finamore,Luigi Minale,et al.Starfish saponins,part 49 new cytotoxic steroidal glycosides from the starfish Fromia Monilts[J].Journal of Natural Products,1993,56(1):105-115.
[178]王兵,郑意端.海星总皂苷抗肿瘤作用的实验研究[J].中草药,2001,32(3):244-245.
[179]汤海峰,易杨华,张淑瑜,等.海星皂苷的研究进展[J].中国海洋药物,2004,12(23):48-57.
[180]孙鹏,易杨华,李玲,等.海参皂苷的生源分类和化学结构特征(枝手目)[J].中国天然药物,2008,6(4):241-250.
[181]张立新,薛峰,赵爱云,等.海星中皂苷总含量测定方法的研究[J].食品科学,2007,28(1):243-246.
[182]董平,薛长湖,盛文静,等.海参中总皂苷含量测定方法的研究[J].中国海洋药物,2008,27(1):28-32.
[183]陈方,宋海峰.皂苷分析方法研究进展[J].天津中医药,2005,22(3):257-259.
[184]文镇,朱志鑫,申德妍,等.紫外分光光度法测定海星皂甙的含量[J].分析科学学报,2004,12,20(6):592-594.
[185]郭承华,刘传琳,张传钦,等.砂海星海星皂苷的制备[J].中国海洋药物,1997,1:36-39.
[186]阎伟,宗世祥,骆有庆,等.逐步回归模型在油蒿钻蛀性害虫预测中的应用[J].北京林业大学学报,2009,31:140-144.
[187] Fujita M,Nishimoto K. On the biological assay of Japanese senega[J]. J Pharm Soc Japan,1952,72:1645-1654.
[188]郭承华.海燕皂苷及其它活性物质的制备及其生物功能研究[D].中国海洋大学, 2005.
[189]郭承华,金海洙,倪新江,等.金氏真蛇尾(Ophiura kinbergi)蛇尾皂甙的制备及特性研究[J].动物学报,2001,47:131-133.
[190] H Ahsan,A Ali,R Ali.Oxygen free radicals and systemic autoimmunity[J] Clin Exp Immunol. 2003,3, 131 (3): 398-404.
[191] Soichi Hanaoka,Jin-Ming Lin,Masaaki Yamada.Chemiluminescence behavior of the decomposition of hydrogen peroxide catalyzed by copper(II)–amino acid complexes and its application to the determination of tryptophan and phenylalanine[J] Analytica Chimica Acta,2000,3:65-73
[192] Jian L,Chen Q.Effect of carbon disulfide on pyrogallol-luminol auto-oxidation chemiluminescence system and superoxide anion[J].Ophthalmology,2000 ,5,;34(3):162-164.
[193] Francisco J.Perez,Sebastian Rubio. An improved chemiluminescence method for hydrogen peroxide determination in plant tissues[J]. Plant Growth Regulation,2006,48:89-95.
[194]王洪欣,张立新.海星中皂苷类化学成分的研究进展[J].天然产物研究与开发,2005,17:96-103.
[195]姜健,杨宝灵,邰阳.海参资源及其生物活性物质的研究[J].生物技术通讯,2004,15(5):537-540.
[196]马天舒,葛迎春.海参活性物质的药理研究进展[J].特产研究,2003,1:57-61.
[197]沈萍,范秀容,李广武.微生物学实验(第三版)[M].高等教育出版社,1999,6:100-101.
[198]湛学军,熊远珍,柳喆,等.羧甲基壳聚糖银的合成及抑菌实验的研究[J].中国生化药物杂志,2001, 22(3):142-144.
[199]刘雪梅,朱艳丽.甲壳胺体内外抑菌试验及其抑菌机理的研究[J].山东农业大学学报(自然科学版),2008,39(3):365-370.
[200]赵瑞利,韩文瑜,韩俊友,等.牛蛙皮肤抗菌肽的分离纯化与活性测定[J].中国生物制品学杂志,2008,21(8):694-697.
[201]丛日山,袁文鹏,樊廷俊,等.仿刺参水溶性海参皂苷的分离制备及抗真菌活性的研究[J].中国海洋大学学报,2006,11,36(6):959-964.
[202]苏永昌,刘淑集,吴成业.海参皂苷的分离提取与生物活性[J].福建水产,2008,1:66-69.
[203]罗显华,郁建生.大孔吸附树脂分离纯化鱼腥草总黄酮[J].中国民族民间医药,2008,17(8):7-11.
[204]战克勤,黄学才,孙健.药用全蝎含水量、含盐量的测定[J].中国药品标准,2004, 5(3):24-25.
[205]钟露苗.三萜皂苷提取分离和结构鉴定技术[J].中医药学刊,2004,22(4):760-762.
[206]黄银久,宋宝安,金林红,等.SRB法和MTT法抗肿瘤药物筛选结果相关性研究[J].生物学杂志,2009,4:13-16.
[207]李明,缪泽鸿,陈志,等.海洋来源的新三菇皂昔类化合物Echinoside A的抗肿瘤作用及机制[A]. 2009医学前沿论坛暨第十一届全国肿瘤药理与化疗学术会议论文集,2009.136-137.